AU2003218870A1 - Treatment for diseases of the eye, inner ear and central nervous system - Google Patents
Treatment for diseases of the eye, inner ear and central nervous systemInfo
- Publication number
- AU2003218870A1 AU2003218870A1 AU2003218870A AU2003218870A AU2003218870A1 AU 2003218870 A1 AU2003218870 A1 AU 2003218870A1 AU 2003218870 A AU2003218870 A AU 2003218870A AU 2003218870 A AU2003218870 A AU 2003218870A AU 2003218870 A1 AU2003218870 A1 AU 2003218870A1
- Authority
- AU
- Australia
- Prior art keywords
- diseases
- eye
- treatment
- nervous system
- central nervous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
- C12Y114/18001—Tyrosinase (1.14.18.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Eye Examination Apparatus (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10206723.6 | 2002-02-18 | ||
DE10206723A DE10206723A1 (de) | 2002-02-18 | 2002-02-18 | Therapie von Erkrankungen des Auges und des Zentralen Nervensystems |
PCT/DE2003/000415 WO2003070269A1 (de) | 2002-02-18 | 2003-02-12 | Therapie von erkrankungen des auges, des innenohres und des zentralen nervensystems |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003218870A1 true AU2003218870A1 (en) | 2003-09-09 |
Family
ID=27674717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003218870A Abandoned AU2003218870A1 (en) | 2002-02-18 | 2003-02-12 | Treatment for diseases of the eye, inner ear and central nervous system |
Country Status (6)
Country | Link |
---|---|
US (1) | US7488749B2 (de) |
EP (1) | EP1478389B1 (de) |
AT (1) | ATE419864T1 (de) |
AU (1) | AU2003218870A1 (de) |
DE (3) | DE10206723A1 (de) |
WO (1) | WO2003070269A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491699B2 (en) | 2002-12-09 | 2009-02-17 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures and methods of generating and using the same |
WO2004060791A1 (en) | 2003-01-07 | 2004-07-22 | Ramot At Tel Aviv University Ltd. | Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
US20050226825A1 (en) * | 2004-04-13 | 2005-10-13 | Giampapa Vincent C | Topical composition for preventing and treating skin damage caused by UV light exposure |
US8568637B2 (en) | 2004-08-02 | 2013-10-29 | Ramot At Tel-Aviv University Ltd. | Method of forming a fiber made of peptide nanostructures |
WO2006018850A2 (en) | 2004-08-19 | 2006-02-23 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
JP5079503B2 (ja) * | 2005-06-07 | 2012-11-21 | 株式会社インバイオテックス | ラジカルスカベンジャー及び活性酸素消去剤 |
WO2007013147A1 (ja) * | 2005-07-27 | 2007-02-01 | Inbiotex Inc. | 血管新生阻害剤及び血管退縮剤 |
WO2007043048A2 (en) | 2005-10-11 | 2007-04-19 | Ramot At Tel Aviv University Ltd. | Self-assembled fmoc-ff hydrogels |
CA2721360A1 (en) * | 2008-04-18 | 2009-10-22 | Arizona Board Of Regents, A Body Corp. Of The State Of Arizona, Acting F Or And On Behalf Of The University Of Arizona | Methods and compositions for treating and identifying compounds to treat age-related macular degeneration |
JP5815552B2 (ja) | 2009-12-08 | 2015-11-17 | ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University | 眼疾患を治療する化合物および方法 |
KR20150047158A (ko) * | 2013-10-24 | 2015-05-04 | 삼성전자주식회사 | 스트레스 관리 시스템 및 그 방법 |
EP3927330A4 (de) * | 2019-02-19 | 2022-11-30 | The Regents of the University of California | Nurr1-rezeptormodulatoren |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01112483A (ja) * | 1987-10-27 | 1989-05-01 | Matsushita Electric Works Ltd | 熱線式検知器 |
US5210076A (en) | 1988-09-13 | 1993-05-11 | Berliner David L | Methods of treating Parkinson's disease using melanin |
US5126125A (en) * | 1989-10-06 | 1992-06-30 | Yale University | Decreasing the melanin content in mammalian skin and hair using 5,6-dihydroxindole derivatives |
US5686084A (en) | 1995-12-06 | 1997-11-11 | Clairol Incorporated | Synthesis of quaternary melanin compounds and their use as hair dyes or for skin treatment |
US6022526A (en) * | 1997-07-30 | 2000-02-08 | Pharmacyclics, Inc. | Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma |
CA2341903A1 (en) | 1998-08-21 | 2000-03-02 | The Children's Medical Center Corporation | Use of melanin for inhibition of angiogenesis and macular degeneration |
DE50213781D1 (de) | 2001-02-21 | 2009-10-01 | Cevec Pharmaceuticals Gmbh | Pigmentepithelzelle des auges, ihre herstellung und verwendung in der therapie einer augen- oder zns-erkrankung |
-
2002
- 2002-02-18 DE DE10206723A patent/DE10206723A1/de not_active Withdrawn
-
2003
- 2003-02-12 AU AU2003218870A patent/AU2003218870A1/en not_active Abandoned
- 2003-02-12 EP EP03714635A patent/EP1478389B1/de not_active Expired - Lifetime
- 2003-02-12 US US10/505,030 patent/US7488749B2/en not_active Expired - Fee Related
- 2003-02-12 WO PCT/DE2003/000415 patent/WO2003070269A1/de not_active Application Discontinuation
- 2003-02-12 DE DE50311048T patent/DE50311048D1/de not_active Expired - Fee Related
- 2003-02-12 DE DE10390601T patent/DE10390601D2/de not_active Expired - Lifetime
- 2003-02-12 AT AT03714635T patent/ATE419864T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE10390601D2 (de) | 2005-01-27 |
ATE419864T1 (de) | 2009-01-15 |
EP1478389B1 (de) | 2009-01-07 |
US20050142128A1 (en) | 2005-06-30 |
WO2003070269A1 (de) | 2003-08-28 |
DE10206723A1 (de) | 2003-09-04 |
EP1478389A1 (de) | 2004-11-24 |
DE50311048D1 (de) | 2009-02-26 |
US7488749B2 (en) | 2009-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003276028A1 (en) | Pyridine derivatives as cb2 receptor modulators | |
WO2003032994A3 (de) | 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren | |
AU2003218870A1 (en) | Treatment for diseases of the eye, inner ear and central nervous system | |
MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
WO2004072031A8 (en) | Phenylacetamides and their use as glucokinase modulators | |
WO2005013892A3 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
RS20050104A (en) | Indole or benzimidazole derivatives for modulating ikb kinase | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
AU6050600A (en) | Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidaseenzyme for the manufacture of medicament for the treatment of glycolipid storag e diseases | |
AU3126600A (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
AU2003255819A1 (en) | Pyrimidine derivatives as modulators of chemokine receptor activity | |
WO2005087210A3 (en) | Prevention of retinopathy by inhibition of the visual cycle | |
AU3850600A (en) | Dalda analogs and their use | |
AU2002352531A1 (en) | Use of at least one glycoinhibitor substance | |
HUP0202745A2 (hu) | Profilaktikus és terápiás szerek szembetegségek kezelésére | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
AU2002359162A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
BR0112807A (pt) | Derivados de indol e sua aplicação como medicamento | |
DE59904180D1 (de) | Cyclopentabenzofuran-derivate und ihre verwendung | |
WO2005013911A3 (en) | Protective and therapeutic uses for tocotrienols | |
WO2002100836A8 (en) | Compounds, compositions and methods for modulating beta-amyloid production | |
GR3025568T3 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |